Nifedikor

Nifedicor

Pharm-Group: calcium channel blockers of the dihydropyridoline group

Pharmacological action: prevents the slow entry of calcium ions into cardiomyocytes, that is, the development of atherosclerosis is prevented, aggregation and permeability of capillary walls are reduced, muscle tone in the heart is stabilized. For arterial hypertension, it increases the elasticity of large arteries and reduces peripheral vascular resistance (without affecting blood pressure); for angina pectoris, it reduces pain due to vasodilation. These